{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:49:14Z","timestamp":1790682554183,"version":"4.1.0"},"reference-count":83,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":642,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["93526\/2013"],"award-info":[{"award-number":["93526\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Systemic sclerosis (SSc) is a severe autoimmune fibrotic disease characterized by fibrosis, vasculopathy, and immune dysregulation. Dendritic cells (DCs) are the most potent antigen-presenting cells, specialized in pathogen sensing, with high capacity to shape the immune responses. The most recent technological advances have allowed the discovery of new DC subsets with potential implications in inflammatory conditions. Alterations of DC distribution in circulation and affected tissue as well as impaired DC function have been described in SSc patients, pointing towards a crucial role of these cells in SSc pathogenesis. In particular, recent studies have shown the importance of plasmacytoid DCs either by their high capacity to produce type I interferon or other inflammatory mediators implicated in SSc pathology, such as chemokine C-X-C motif ligand 4 (CXCL4). In-vivo models of SSc have been vital to clarify the implications of DCs in this disease, especially DCs depletion and specific gene knock-down studies. This review provides these new insights into the contribution of the different DCs subsets in the pathogenesis of SSc, as well as to the novel developments on DCs in in-vivo models of SSc and the potential use of DCs and their mediators as therapeutic targets.<\/jats:p>","DOI":"10.1111\/cei.13417","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T07:12:48Z","timestamp":1579763568000},"page":"25-33","source":"Crossref","is-referenced-by-count":39,"title":["Novel insights into dendritic cells in the pathogenesis of systemic sclerosis"],"prefix":"10.1093","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3187-2288","authenticated-orcid":false,"given":"T","family":"Carvalheiro","sequence":"first","affiliation":[{"name":"Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T R D J","family":"Radstake","sequence":"additional","affiliation":[{"name":"Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9039-2658","authenticated-orcid":false,"given":"W","family":"Marut","sequence":"additional","affiliation":[{"name":"Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"2022011418210808800_cei13417-bib-0001","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"2022011418210808800_cei13417-bib-0002","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2022011418210808800_cei13417-bib-0003","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","article-title":"Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities","volume":"8","author":"Bhattacharyya","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"2022011418210808800_cei13417-bib-0004","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cei.13238","article-title":"The immunopathogenesis of fibrosis in systemic sclerosis","volume":"195","author":"Brown","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"2022011418210808800_cei13417-bib-0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pharmthera.2018.08.003","article-title":"Targeting TLRs and the inflammasome in systemic sclerosis","volume":"192","author":"Henderson","year":"2018","journal-title":"Pharmacol Ther"},{"key":"2022011418210808800_cei13417-bib-0006","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/CS20140467","article-title":"Pound the alarm: danger signals in rheumatic diseases","volume":"128","author":"O'Reilly","year":"2015","journal-title":"Clin Sci"},{"key":"2022011418210808800_cei13417-bib-0007","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N Engl J Med"},{"key":"2022011418210808800_cei13417-bib-0008","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13075-016-1203-y","article-title":"Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease","volume":"18","author":"Volkmann","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2022011418210808800_cei13417-bib-0009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11926-011-0215-5","article-title":"Dendritic cells: novel players in fibrosis and scleroderma","volume":"14","author":"Lu","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"2022011418210808800_cei13417-bib-0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.imlet.2017.11.003","article-title":"Dendritic cells in systemic sclerosis: advances from human and mice studies","volume":"195","author":"Affandi","year":"2018","journal-title":"Immunol Lett"},{"key":"2022011418210808800_cei13417-bib-0011","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.autrev.2018.06.013","article-title":"Recent advances in mouse models for systemic sclerosis","volume":"17","author":"Yue","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2022011418210808800_cei13417-bib-0012","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fimmu.2014.00131","article-title":"Human dendritic cell functional specialization in steady-state and inflammation","volume":"5","author":"Boltjes","year":"2014","journal-title":"Front Immunol"},{"key":"2022011418210808800_cei13417-bib-0013","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.4049\/jimmunol.1601629","article-title":"The importance of dendritic cells in maintaining immune tolerance","volume":"198","author":"Audiger","year":"2017","journal-title":"J Immunol"},{"key":"2022011418210808800_cei13417-bib-0014","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00281-016-0583-z","article-title":"Dendritic cells as gatekeepers of tolerance","volume":"39","author":"Waisman","year":"2017","journal-title":"Semin Immunopathol"},{"key":"2022011418210808800_cei13417-bib-0015","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrrheum.2016.147","article-title":"Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles","volume":"12","author":"Coutant","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2022011418210808800_cei13417-bib-0016","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/intimm\/dxs006","article-title":"Enumeration of human peripheral blood dendritic cells throughout the life","volume":"24","author":"Orsini","year":"2012","journal-title":"Int Immunol"},{"key":"2022011418210808800_cei13417-bib-0017","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"2022011418210808800_cei13417-bib-0018","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"2022011418210808800_cei13417-bib-0019","doi-asserted-by":"crossref","first-page":"eaag3009","DOI":"10.1126\/science.aag3009","article-title":"Mapping the human DC lineage through the integration of high-dimensional techniques","volume":"356","author":"See","year":"2017","journal-title":"Science"},{"key":"2022011418210808800_cei13417-bib-0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"Swiecki","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2022011418210808800_cei13417-bib-0021","doi-asserted-by":"crossref","first-page":"eaah4573","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science"},{"key":"2022011418210808800_cei13417-bib-0022","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41590-018-0136-9","article-title":"Distinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells","volume":"19","author":"Rodrigues","year":"2018","journal-title":"Nat Immunol"},{"key":"2022011418210808800_cei13417-bib-0023","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41590-017-0012-z","article-title":"Diversification of human plasmacytoid predendritic cells in response to a single stimulus","volume":"19","author":"Alculumbre","year":"2018","journal-title":"Nat Immunol"},{"key":"2022011418210808800_cei13417-bib-0024","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.cell.2019.09.035","article-title":"Transcriptional basis of mouse and human dendritic cell heterogeneity","volume":"179","author":"Brown","year":"2019","journal-title":"Cell"},{"key":"2022011418210808800_cei13417-bib-0025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.immuni.2019.08.008","article-title":"Single-cell analysis of human mononuclear phagocytes reveals subset-defining markers and identifies circulating inflammatory dendritic cells","volume":"51","author":"Dutertre","year":"2019","journal-title":"Immunity"},{"key":"2022011418210808800_cei13417-bib-0026","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2022011418210808800_cei13417-bib-0027","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2022011418210808800_cei13417-bib-0028","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"2022011418210808800_cei13417-bib-0029","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.immuni.2017.02.019","article-title":"Dendritic Cells Display Subset and Tissue-Specific Maturation Dynamics over Human Life","volume":"46","author":"Granot","year":"2017","journal-title":"Immunity"},{"key":"2022011418210808800_cei13417-bib-0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1165\/rcmb.2016-0272TR","article-title":"Lung dendritic cells: shaping immune responses throughout chronic obstructive pulmonary disease progression","volume":"56","author":"Freeman","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2022011418210808800_cei13417-bib-0031","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jaci.2014.05.045","article-title":"Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27\/IL-10\/inducible costimulator ligand","volume":"134","author":"Tsoumakidou","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2022011418210808800_cei13417-bib-0032","doi-asserted-by":"crossref","first-page":"e98380","DOI":"10.1172\/jci.insight.98380","article-title":"pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis","volume":"3","author":"Kafaja","year":"2018","journal-title":"JCI Insight"},{"key":"2022011418210808800_cei13417-bib-0033","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/ijms19010042","article-title":"The origin of skin dendritic cell network and its role in psoriasis","volume":"19","author":"Kim","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2022011418210808800_cei13417-bib-0034","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev-immunol-051116-052215","article-title":"Antigen-presenting cells in the skin","volume":"35","author":"Kashem","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"2022011418210808800_cei13417-bib-0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13075-015-0785-0","article-title":"CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosis","volume":"17","author":"Mokuda","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2022011418210808800_cei13417-bib-0036","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/art.24688","article-title":"STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis","volume":"60","author":"Dieude","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022011418210808800_cei13417-bib-0037","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/art.24600","article-title":"Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population","volume":"60","author":"Ito","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022011418210808800_cei13417-bib-0038","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddp119","article-title":"The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype","volume":"18","author":"Rueda","year":"2009","journal-title":"Hum Mol Genet"},{"key":"2022011418210808800_cei13417-bib-0039","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1002\/art.24958","article-title":"Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1\/Th2 cytokines","volume":"60","author":"Gourh","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022011418210808800_cei13417-bib-0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imlet.2017.10.011","article-title":"Targeting interferons as a strategy for systemic sclerosis treatment","volume":"195","author":"Ciechomska","year":"2018","journal-title":"Immunol Lett"},{"key":"2022011418210808800_cei13417-bib-0041","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/BOR.0000000000000659","article-title":"Role of type I interferons and innate immunity in systemic sclerosis: unbalanced activities on distinct cell types?","volume":"31","author":"Barrat","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"2022011418210808800_cei13417-bib-0042","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/s41467-019-09683-z","article-title":"CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-alpha production in systemic sclerosis","volume":"10","author":"Lande","year":"2019","journal-title":"Nat Commun"},{"key":"2022011418210808800_cei13417-bib-0043","doi-asserted-by":"crossref","first-page":"eaam8458","DOI":"10.1126\/scitranslmed.aam8458","article-title":"Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8","volume":"10","author":"Ah Kioon","year":"2018","journal-title":"Sci Transl Med"},{"key":"2022011418210808800_cei13417-bib-0044","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1002\/art.30548","article-title":"A one-year, phase I\/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung disease","volume":"63","author":"Khanna","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2022011418210808800_cei13417-bib-0045","doi-asserted-by":"crossref","DOI":"10.1186\/ar4606","article-title":"Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study","volume":"16","author":"Fraticelli","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2022011418210808800_cei13417-bib-0046","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/ard.2009.128207","article-title":"Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis","volume":"69","author":"van Bon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2022011418210808800_cei13417-bib-0047","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00011-017-1106-7","article-title":"Increased frequencies of circulating CXCL10-, CXCL8- and CCL4-producing monocytes and Siglec-3-expressing myeloid dendritic cells in systemic sclerosis patients","volume":"67","author":"Carvalheiro","year":"2018","journal-title":"Inflamm Res"},{"key":"2022011418210808800_cei13417-bib-0048","doi-asserted-by":"crossref","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis","volume":"12","author":"Higashi-Kuwata","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2022011418210808800_cei13417-bib-0049","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2478\/v10039-012-0076-9","article-title":"Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis","volume":"58","author":"Bielecki","year":"2013","journal-title":"Adv Med Sci"},{"key":"2022011418210808800_cei13417-bib-0050","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10067-012-1972-x","article-title":"Increased serum levels of soluble CD163 in patients with scleroderma","volume":"31","author":"Shimizu","year":"2012","journal-title":"Clin Rheumatol"},{"key":"2022011418210808800_cei13417-bib-0051","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/art.37777","article-title":"PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population","volume":"65","author":"Terao","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022011418210808800_cei13417-bib-0052","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41590-018-0179-y","article-title":"PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing","volume":"19","author":"Gavin","year":"2018","journal-title":"Nat Immunol"},{"key":"2022011418210808800_cei13417-bib-0053","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.jid.2018.04.003","article-title":"Deregulated PSGL-1 expression in B cells and dendritic cells may be implicated in human systemic sclerosis development","volume":"138","author":"Silvan","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2022011418210808800_cei13417-bib-0054","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.immuni.2012.10.018","article-title":"Human inflammatory dendritic cells induce Th17 cell differentiation","volume":"38","author":"Segura","year":"2013","journal-title":"Immunity"},{"key":"2022011418210808800_cei13417-bib-0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4049\/jimmunol.1602020","article-title":"CXCL4 exposure potentiates TLR-driven polarization of human monocyte-derived dendritic cells and increases stimulation of T cells","volume":"199","author":"Silva-Cardoso","year":"2017","journal-title":"J Immunol"},{"key":"2022011418210808800_cei13417-bib-0056","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.molimm.2019.09.004","article-title":"CXCL4 is a driver of cytokine mRNA stability in monocyte-derived dendritic cells","volume":"114","author":"Silva-Cardoso","year":"2019","journal-title":"Mol Immunol"},{"key":"2022011418210808800_cei13417-bib-0057","article-title":"CXCL4 links inflammation and fibrosis through transcriptional and epigenetic reprogramming of monocyte-derived cells","author":"Silva-Cardoso","year":"2019","journal-title":"BioRxiv"},{"key":"2022011418210808800_cei13417-bib-0058","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4049\/jimmunol.1502479","article-title":"Bone marrow CD11c+ cell-derived amphiregulin promotes pulmonary fibrosis","volume":"197","author":"Ding","year":"2016","journal-title":"J Immunol"},{"key":"2022011418210808800_cei13417-bib-0059","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/08916934.2016.1230848","article-title":"Topoisomerase I peptide-loaded dendritic cells induce autoantibody response as well as skin and lung fibrosis","volume":"49","author":"Mehta","year":"2016","journal-title":"Autoimmunity"},{"key":"2022011418210808800_cei13417-bib-0060","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.4049\/jimmunol.1103538","article-title":"Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease","volume":"188","author":"Kavian","year":"2012","journal-title":"J Immunol"},{"key":"2022011418210808800_cei13417-bib-0061","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature12614","article-title":"Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma","volume":"503","author":"Gerber","year":"2013","journal-title":"Nature"},{"key":"2022011418210808800_cei13417-bib-0062","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1172\/JCI85740","article-title":"Dendritic cells maintain dermal adipose-derived stromal cells in skin fibrosis","volume":"126","author":"Chia","year":"2016","journal-title":"J Clin Invest"},{"key":"2022011418210808800_cei13417-bib-0063","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1182\/blood-2015-11-680876","article-title":"Corruption of dendritic cell antigen presentation during acute GVHD leads to regulatory T-cell failure and chronic GVHD","volume":"128","author":"Leveque-El Mouttie","year":"2016","journal-title":"Blood"},{"key":"2022011418210808800_cei13417-bib-0064","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4049\/jimmunol.1502190","article-title":"Type I IFNs regulate inflammation, vasculopathy, and fibrosis in chronic cutaneous graft-versus-host disease","volume":"197","author":"Delaney","year":"2016","journal-title":"J Immunol"},{"key":"2022011418210808800_cei13417-bib-0065","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1136\/annrheumdis-2015-208213","article-title":"Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis","volume":"75","author":"Ponsoye","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022011418210808800_cei13417-bib-0066","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","article-title":"Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma","volume":"112","author":"Yamamoto","year":"1999","journal-title":"J Invest Dermatol"},{"key":"2022011418210808800_cei13417-bib-0067","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/annrheumdis-2018-214991","article-title":"Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis","volume":"78","author":"Affandi","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2022011418210808800_cei13417-bib-0068","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"key":"2022011418210808800_cei13417-bib-0069","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"key":"2022011418210808800_cei13417-bib-0070","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/MOH.0000000000000531","article-title":"Application of stem cell transplantation in autoimmune diseases","volume":"26","author":"Ng","year":"2019","journal-title":"Curr Opin Hematol"},{"key":"2022011418210808800_cei13417-bib-0071","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022011418210808800_cei13417-bib-0072","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.bbmt.2018.06.025","article-title":"Systemic sclerosis as an indication for autologous hematopoietic cell transplantation: position statement from the American Society for Blood and Marrow Transplantation","volume":"24","author":"Sullivan","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"2022011418210808800_cei13417-bib-0073","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3389\/fimmu.2018.02013","article-title":"Mesenchymal stromal cells based therapy in systemic sclerosis: rational and challenges","volume":"9","author":"Peltzer","year":"2018","journal-title":"Front Immunol"},{"key":"2022011418210808800_cei13417-bib-0074","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/annrheumdis-2018-214024","article-title":"Tolerising cellular therapies: what is their promise for autoimmune disease?","volume":"78","author":"Mosanya","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2022011418210808800_cei13417-bib-0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022011418210808800_cei13417-bib-0076","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.41055","article-title":"Abatacept in early diffuse cutaneous systemic sclerosis: results of a Phase II investigator-initiated, multicenter, double-blind, randomized, placebo-controlled trial","volume":"72","author":"Khanna","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2022011418210808800_cei13417-bib-0077","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a Phase 2, randomised, controlled trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"key":"2022011418210808800_cei13417-bib-0078","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/annrheumdis-2017-211682","article-title":"Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a Phase II randomised controlled trial (faSScinate)","volume":"77","author":"Khanna","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2022011418210808800_cei13417-bib-0079","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2022011418210808800_cei13417-bib-0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","article-title":"Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis","volume":"10","author":"Baraut","year":"2010","journal-title":"Autoimmun Rev"},{"key":"2022011418210808800_cei13417-bib-0081","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(13)60594-2","article-title":"Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the Phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial","volume":"382","author":"McInnes","year":"2013","journal-title":"Lancet"},{"key":"2022011418210808800_cei13417-bib-0082","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s40264-019-00797-3","article-title":"Ustekinumab safety in psoriasis, psoriatic arthritis, and Crohn's disease: an integrated analysis of Phase II\/III clinical development programs","volume":"42","author":"Ghosh","year":"2019","journal-title":"Drug Saf"},{"key":"2022011418210808800_cei13417-bib-0083","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.ajpath.2016.12.016","article-title":"Blockade of p38 mitogen-activated protein kinase inhibits murine sclerodermatous chronic graft-versus-host disease","volume":"187","author":"Matsushita","year":"2017","journal-title":"Am J Pathol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.13417","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.13417","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.13417","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/201\/1\/25\/42195758\/cei13417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/201\/1\/25\/42195758\/cei13417.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T13:57:21Z","timestamp":1665583041000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/201\/1\/25\/6401621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,2,13]]},"published-print":{"date-parts":[[2020,6,11]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13417","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,2,13]]}}}